Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Fibrosis × Aspirin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 22 Neoplasms 13 Colonic Neoplasms 10 Breast Neoplasms 10 Venous Thromboembolism 8 Prostatic Neoplasms 8 Multiple Myeloma 7 Recurrence 6 Polycythemia Vera 6 Carcinoma, Non-Small-Cell Lung 6 Thrombocythemia, Essential 4 Neoplasms, Plasma Cell 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Thrombosis 2 Sarcoma 2 Rectal Neoplasms 2 Primary Myelofibrosis 2 Pancreatic Neoplasms 2 Neoplastic Cells, Circulating 2 Neoplasms by Site 2 Myocardial Infarction 2 Lung Neoplasms 2 Intestinal Neoplasms 2 Intestinal Diseases 2 Inflammation 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2

Interventions

Blood Specimen Collection 7 Pentoxifylline 4 Liver Transplantation 4 Magnetic Resonance Spectroscopy 3 Tocopherols 2 Low-Level Light Therapy 2 High-Energy Shock Waves 2 tremelimumab 1 sonidegib 1 maltodextrin 1 epigallocatechin gallate 1 durvalumab 1 contrast agent BR1 1 bavituximab 1 apixaban 1 alpha-Tocopherol 1 Vitamin E 1 Vitamin D 1 User-Centered Design 1 Tenofovir 1 Surveys and Questionnaires 1 Sunitinib 1 Standard of Care 1 Spermine Synthase 1 Specimen Handling 1 Sorafenib 1 Sonazoid 1 Sodium Chloride 1 Sampling Studies 1 Restraint, Physical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07529262 2026-04-14

AspiRe HCC

Curtin University

Phase 3 Not yet recruiting

Carcinoma, Fibrosis, Liver Cirrhosis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡